Skip to main content

and
  1. No Access

    Article

    Immune-checkpoint inhibition for resectable non-small-cell lung cancer — opportunities and challenges

    Therapeutic strategies harnessing the immune system to eliminate tumour cells have been successfully used for several cancer types, including in patients with advanced-stage non-small-cell lung cancer (NSCLC)....

    Giannis Mountzios, Jordi Remon, Lizza E. L. Hendriks in Nature Reviews Clinical Oncology (2023)

  2. Article

    Open Access

    Real-world safety and efficacy data of immunotherapy in patients with cancer and autoimmune disease: the experience of the Hellenic Cooperative Oncology Group

    Data on the safety and efficacy of immune checkpoint inhibitors (ICI) in patients with concurrent autoimmune diseases (AID) are limited.

    Elena Fountzilas, Sofia Lampaki in Cancer Immunology, Immunotherapy (2022)

  3. No Access

    Chapter

    Germ-Cell Tumors

    Cancer originating from germ cells is a special disease, characterized by increased incidence in young men (18–40 years) and extremely good prognosis, even if it is diagnosed in advanced stages. The vast major...

    Giannis Mountzios in International Manual of Oncology Practice (2019)

  4. No Access

    Article

    Management of NSCLC Disease Progression After First-Line EGFR Tyrosine Kinase Inhibitors: What Are the Issues and Potential Therapies?

    Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) represent the standard of care for advanced non-small cell lung cancer (NSCLC) patients whose tumor harbors an activating EGFR mutation...

    Raffaele Califano, Ourania Romanidou, Giannis Mountzios, Lorenza Landi in Drugs (2016)

  5. No Access

    Book

    International Manual of Oncology Practice

    (iMOP) - Principles of Medical Oncology

    Ramon Andrade de Mello, Álvaro Tavares (2015)

  6. No Access

    Chapter

    Molecular Features and Treatment Modalities of “Classic” Versus Human Papilloma Virus-Associated Head and Neck Cancer

    Human papilloma virus (HPV)-associated squamous cell carcinoma of the head and neck (SCCHN) represents a unique disease entity, with distinct epidemiological and molecular characteristics fr...

    Giannis Mountzios, Amanda Psyrri MD in Molecular Determinants of Head and Neck Cancer (2014)

  7. No Access

    Article

    A Benefit-Risk Assessment of Erlotinib in Non-Small-Cell Lung Cancer and Pancreatic Cancer

    Non-small-cell lung cancer (NSCLC) and pancreatic cancer represent two major causes of cancer-related morbidity and mortality worldwide. Conventional cytotoxic agents seem to have reached a therapeutic plateau...

    Giannis Mountzios, Kostas N. Syrigos in Drug Safety (2011)

  8. No Access

    Article

    Mechanisms of Disease: signal transduction in lung carcinogenesis—a comparison of smokers and never-smokers

    Our understanding of the pathogenesis of tobacco-related lung carcinogenesis is improving but the molecular mechanisms of neoplastic transformation in never-smokers have not yet been elucidated. Mountzios et al. ...

    Giannis Mountzios, Pierre Fouret, Jean-Charles Soria in Nature Clinical Practice Oncology (2008)

  9. Article

    Open Access

    Concurrent development of testicular seminoma and choriocarcinoma of the superior mediastinum, presented as cervical mass: a case report and implications about pathogenesis of germ-cell tumours

    Synchronous presentation of more than one germ cell tumours of different histology in the same patient is considered to be very rare. In these cases of multiple germ cell tumours, strong theoretical and clinic...

    Giannis Mountzios, George Pavlakis, Evangelos Terpos in BMC Clinical Pathology (2006)

  10. No Access

    Article

    Advanced non-small-cell lung cancer: 'triplets' better than 'doublets'?

    Giannis Mountzios, Jean-Charles Soria in Nature Clinical Practice Oncology (2006)